Johnson & Johnson (JNJ)

$ 159.86
   
  • Change Today:
    $-0.75
  • 52 Week High: $167.38
  • 52 Week Low: $144.38
  • Currency: US Dollars
  • Shares Issued: 2,407.08m
  • Volume: 8,612,402
  • Market Cap: $384,796m
  • RiskGrade: 87

EMA says no urgent need yet for booster Covid-19 vaccine doses

By Alexander Bueso

Date: Thursday 21 Oct 2021

LONDON (ShareCast) - (Sharecast News) - There is no urgent need to give healthy adults a third Covid-19 vaccine dose, Europe's health regulator said.
More vulnerable older people, especially those at care homes, could be given another dose, as should those with suppressed immune systems, such as organ-transplant patients.

Instead, the EMA said that the focus ought to be on inoculating the roughly one-third of Europeans who had not yet received any shot.

The day before, the head of the World Health Organisation, Tedros Adhanom Ghebreyesus, had repeated his call for countries not to engage in mass booster programmes at least until October.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 159.86
Change Today $ -0.75
% Change -0.47 %
52 Week High $167.38
52 Week Low $144.38
Volume 8,612,402
Shares Issued 2,407.08m
Market Cap $384,796m
RiskGrade 87

What The Brokers Say

Strong Buy 5
Buy 6
Neutral 12
Sell 0
Strong Sell 0
Total 23
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 31-Oct-2024

Time Volume / Share Price
15:59 100 @ $159.86
15:59 321 @ $159.86
15:59 162 @ $159.89
15:59 100 @ $159.89
15:59 400 @ $159.86

Top of Page